123 related articles for article (PubMed ID: 27481530)
1. Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana.
Moyo S; Kotokwe KP; Mohammed T; Boleo C; Mupfumi L; Chishala S; Tsalaile L; Bussmann H; Gaseitsiwe S; Musonda R; Makhema J; Baum M; Marlink R; Engelbrecht S; Essex M; Novitsky V
AIDS Res Hum Retroviruses; 2017 Jan; 33(1):17-18. PubMed ID: 27481530
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
[TBL] [Abstract][Full Text] [Related]
3. Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.
Lynch BA; Patel EU; Courtney CR; Nanfack AJ; Bimela J; Wang X; Eid I; Quinn TC; Laeyendecker O; Nyambi PN; Duerr R; Redd AD
AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1114-1116. PubMed ID: 28670965
[TBL] [Abstract][Full Text] [Related]
4. Short Communication: Low False Recent Rate of Limiting-Antigen Avidity Assay Among Long-Term Infected Subjects from Guangxi, China.
Yu L; Laeyendecker O; Wendel SK; Liang F; Liu W; Wang X; Wang L; Pang X; Fang Z
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1247-9. PubMed ID: 26331573
[TBL] [Abstract][Full Text] [Related]
5. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
[TBL] [Abstract][Full Text] [Related]
6. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
[TBL] [Abstract][Full Text] [Related]
7. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
Kim AA; Rehle T
AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
[TBL] [Abstract][Full Text] [Related]
9. Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.
Serhir B; Hamel D; Doualla-Bell F; Routy JP; Beaulac SN; Legault M; Fauvel M; Tremblay C;
PLoS One; 2016; 11(5):e0156023. PubMed ID: 27224023
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
[TBL] [Abstract][Full Text] [Related]
11. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
[TBL] [Abstract][Full Text] [Related]
12. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
[TBL] [Abstract][Full Text] [Related]
13. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
[TBL] [Abstract][Full Text] [Related]
14. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
[TBL] [Abstract][Full Text] [Related]
15. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
[TBL] [Abstract][Full Text] [Related]
16. Development of an avidity assay for detection of recent HIV infections.
Shepherd SJ; McAllister G; Kean J; Wallace LA; Templeton KE; Goldberg DJ; Gunson RN; Aitken C
J Virol Methods; 2015 Jun; 217():42-9. PubMed ID: 25721468
[TBL] [Abstract][Full Text] [Related]
17. Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.
Negedu-Momoh OR; Balogun O; Dafa I; Etuk A; Oladele EA; Adedokun O; James E; Pandey SR; Khamofu H; Badru T; Robinson J; Mastro TD; Torpey K
J Int AIDS Soc; 2021 Feb; 24(2):e25669. PubMed ID: 33619853
[TBL] [Abstract][Full Text] [Related]
18. Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence.
Gao Z; Yan H; Feng X; Wu L; Qiu M; Xing W; Zhang G; Zhang Z; Jiang Y
PLoS One; 2016; 11(8):e0161183. PubMed ID: 27513563
[TBL] [Abstract][Full Text] [Related]
19. Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay.
Longosz AF; Mehta SH; Kirk GD; Margolick JB; Brown J; Quinn TC; Eshleman SH; Laeyendecker O
AIDS; 2014 May; 28(8):1227-32. PubMed ID: 24513567
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece.
Nikolopoulos GK; Katsoulidou A; Kantzanou M; Rokka C; Tsiara C; Sypsa V; Paraskevis D; Psichogiou M; Friedman S; Hatzakis A
Epidemiol Infect; 2017 Jan; 145(2):401-412. PubMed ID: 27780490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
